[The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
出版信息
MMW Fortschr Med. 2003 Jun 12;145(24):52.
PMID:12866303
Abstract
摘要
相似文献
1
[The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
MMW Fortschr Med. 2003 Jun 12;145(24):52.
2
[New antiviral agent. Hepatitis B therapy with slight resistance risk].
MMW Fortschr Med. 2003 Dec 18;145(51-52):40.
3
Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
Z Gastroenterol. 2004 Jan;42(1):15-8. doi: 10.1055/s-2004-812683.
4
[Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
Gastroenterol Clin Biol. 2006 Oct;30(10 Pt 2):3S22-5.
5
Treatment of hepatitis B virus infection in patients coinfected with HIV.
Gastroenterol Clin North Am. 2004 Sep;33(3):617-27, x. doi: 10.1016/j.gtc.2004.04.010.
6
Low-dose adefovir for the treatment of chronic hepatitis B in HIV-infected people.
GMHC Treat Issues. 2001 Nov-Dec;15(11-12):8-11.
7
Adefovir dipivoxil in the treatment of chronic hepatitis B.
Ann Pharmacother. 2004 Apr;38(4):625-33. doi: 10.1345/aph.1D362. Epub 2004 Feb 27.
8
[Entecavir].
Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:39-48. doi: 10.1016/s0213-005x(08)76518-2.
9
HIV and hepatitis B virus: options for managing coinfection.
Top HIV Med. 2003 Jan-Feb;11(1):16-9.
10
Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
Aliment Pharmacol Ther. 2012 Jun;35(12):1482. doi: 10.1111/j.1365-2036.2012.05105.x.
Zotero 插件